Copyright
©The Author(s) 2020.
World J Gastroenterol. Dec 21, 2020; 26(47): 7444-7469
Published online Dec 21, 2020. doi: 10.3748/wjg.v26.i47.7444
Published online Dec 21, 2020. doi: 10.3748/wjg.v26.i47.7444
Figure 8 Bone marrow-derived mesenchymal stem cell transplantation routes for liver disease.
The routes are either direct (portal vein and hepatic artery) or indirect (peripheral vein, intrasplenic, intraperitoneal, bone marrow reconstitution, and extra-corporeal liver assist). BM-MSCs: Bone marrow-derived mesenchymal stem cells.
- Citation: Al-Dhamin Z, Liu LD, Li DD, Zhang SY, Dong SM, Nan YM. Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: A systematic review of in vivo studies. World J Gastroenterol 2020; 26(47): 7444-7469
- URL: https://www.wjgnet.com/1007-9327/full/v26/i47/7444.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i47.7444